Top Pharma Company in India for Quality Medicines – Janus Biotech

  Quick answer: The Vonoprazan HP Kit is a combination therapy for H. pylori eradication that packages Vonoprazan (a potassium-competitive acid blocker) with amoxicillin — and often clarithromycin for triple therapy — plus Domperidone, taken as a coordinated 7-to-14-day course. For a PCD franchise partner, it's structured as a standard monopoly-basis product: a valid drug license, GST registration, and a signed franchise agreement are all that's required to onboard, with first-order values typically in the ₹30,000–₹50,000 range and profit margins around 20–40%, consistent with most monopoly PCD gastro lines. What differs from a standalone tablet product is that pricing, minimum order quantities, and supply reliability are all tied to the full three-component kit rather than a single molecule. The rest of this guide breaks down what's actually in the kit, why it's dosed the way it is, who it's not suited for, and what a franchise partner should specifically check be...

The Janus Pharma Insights is a podcast focused on pharmaceutical innovation, skincare manufacturing, emerging therapies, and business opportunities in the Indian healthcare sector. Through expert discussions and industry insights, we cover topics ranging from third-party manufacturing and PCD pharma franchises to new treatment options and market trends.  Janus Pharma Insights - Podcast by Janus Biotech Our podcast is available across major streaming platforms, including Spotify, Apple Podcasts, Amazon Music, iHeartRadio, Castbox, Podcast Addict, Podchaser, and Spreaker. Explore our latest episodes below and listen on your favorite platform. Episode 1: The Rise of Niacinamide Serum Manufacturing in India This episode explores the increasing demand for niacinamide serum manufacturing in India, private-label skincare production, and the growing opportunities in the cosmetics and pharmaceutical industries. Listen here: Spreaker: https://www.spreaker.com/episode/the-rise-of-niacinamide...

Looking for a reliable Vonoprazan PCD pharma franchise partner? Janus Biotech offers a complete Vonoprazan portfolio including the Vonoprazan HP Kit and Domperidone combination, backed by monopoly distribution rights, WHO-GMP & ISO certified manufacturing, attractive profit margins, timely product delivery, and dedicated marketing support. Vonoprazan is a next-generation P-CAB (Potassium-Competitive Acid Blocker) offering faster and longer-lasting acid suppression compared to conventional options — making it a high-demand product for pharma franchise partners across India. 📞 Contact Janus Biotech today to start your Vonoprazan PCD franchise journey. 🔗 Read the full product guide: https://janus.co.in/vonoprazan-pcd-hp-kit-domperidone-guide/ #VonoprazanPCD #JanusBiotech #PCDPharmaFranchise --- Disclaimer: This video is for business/franchise informational purposes only and does not constitute medical advice. Consult a healthcare professional for treatment decisions.

  Gastro complaints are one of the few therapy categories in Indian pharma where demand almost never slows down — heartburn, acid reflux, and H. pylori-related ulcers are common across every season, every income bracket, and nearly every region. That steady baseline demand is exactly why a Vonoprazan PCD franchise has become one of the more talked-about opportunities in the gastro segment for pharma distributors and first-time franchise entrepreneurs alike. This piece looks at why Vonoprazan-based products are gaining ground with prescribing doctors, what a Vonoprazan PCD pharma franchise business actually involves, and what to check before partnering with any company offering it. Why Gastro Franchise Demand Keeps Climbing in India Acid-related disorders are genuinely common in the Indian population — pooled data across multiple Indian population studies puts GERD prevalence somewhere in the 10–22% range depending on region and lifestyle factors, with urban populations, tobacco u...